All News

An RCT of 1136 newly COVID test positive pts compared long term outcomes if immediately given METFORMIN or Placebo. Cumulative incidence of long COVID at day 300 was 6.3% w/ metformin vs 10.4% w/ placebo (HR 0.59; HR 037 if given w/in 3d) https://t.co/aCTX7xFewW https://t.co/xbBeED9K7U

https://bit.ly/3PozHDZ

Uncertainty can be worrisome. When uncertainty lies ahead, optimism and preparation are your best navigators. Im an optimist. https://t.co/JNzWJFMEfV https://t.co/ltIdy6hNqn

https://bit.ly/3NGTNrY

Small study 57 EGPA pts shows using MTX or AZA to be equipotent as 1st or 2nd line therapy in EGPA. MTX pts used more cumulative steroids (6 g vs 10.7 g @5 yrs) & more AE (66% vs 30%); AZA had fewer asthma/ENT relapses (23% vs 64%, p= 0.04) https://t.co/WZHudojrzk https://t.co/X6xITcQtCw

https://bit.ly/43Mw4w9

RheumNow’s newly launched Poster Hall features sponsor-generated clinical trial posters designed to educate and inform. Posters addressing vasculitis, AxSpa and nrAxSpa, and PMR now available. https://t.co/0dV23VPDQH https://t.co/HfKhji40vU

https://bit.ly/3Jo1bWq

Pediatric Rheumatologist Loan assistance repayment program from HSRA. A loan assistance of up to $100,000 to eligible pediatric medical subspecialists in exchange for a 3-year, full-time service commitment at an approved facility in an underserved area https://t.co/6oFkEEKAY9

https://bit.ly/3PnGGgr

Using Optum claims data from 2009 to 2021, they identified 524 IgG4-RD pts (mean age 56 yrs), incidence increased over time 0.78 to 1.39/100K Pt Yrs 2015 and 2019. Prevalence (1/19) was 5.3/100K Pt-Yrs, w/ mortality rate 3.42/100 Pt-Yrs (HR 2.51) https://t.co/22eIjtC7kp https://t.co/8RlEtZiX9j

https://bit.ly/3Jkk0d8

Rheums! Have a rheumatology question or case for Jack Cush? Record it here and we may feature it on an upcoming podcast. Tell us your name and where you practice rheumatology. https://t.co/3atPdJwb1m https://t.co/MKbgzEi9pd

https://bit.ly/3CFNyOw

NY Times article on a Moral Crisis for Americas doctors - the corporatization of Medicine leverages finances/incomes against physican values and practice preferences. Rheum Dr. Diana Girnita presents the Direct Medical Care option for MD autonomy https://t.co/TySD8l6I94 https://t.co/ZNTx7VVRfg

https://nyti.ms/3CzTpFe

ACR Concerned with MedPAC’s Cutting Part B Reimbursement ACR took issue with the orgs reco to Congress to keep a 6% add-on payment for the lowest-cost drugs, reduce the add-on payment for mid-to-high-level drugs, and add a payment cap for the $$$ drugs. https://t.co/IwZO88QThb https://t.co/GHjDwbHCCo

https://bit.ly/43T7WYQ

RheumNow’s newly launched Poster Hall features sponsor-generated clinical trial posters designed to educate and inform. Check out our Poster Hall today! https://t.co/opulSMICUf https://t.co/XtWePsWQCt

https://bit.ly/43Fk7bo

Why Depression Screening Should be Mandatory at Each Visit Depression is more widespread than ever in the US, according to a new study from Gallup, showing that 18% of adults are depressed– an increase in 7 percentage points since 2015. https://t.co/2u82MXIFvb https://t.co/ZpGi4TYdBL

https://bit.ly/467ujei

Excessive alcohol intake associated with higher risks of 61 diseases in men, including liver cirrhosis, stroke, and several gastrointestinal cancers, gout, cataracts, some fractures, and gastric ulcer. https://t.co/WqMuHQ3Unn https://t.co/IU0SaRcswZ

https://go.nature.com/443iAMc

Artificial Intelligence in Rheumatology: Now and the Future Drs. Antoni Chan and Thomas Hugle discuss abstract POS0892 from EULAR 2023 in Milan, Italy. https://t.co/rftHTKY6MX @synovialjoints https://t.co/PtlKg4o18s

https://bit.ly/3qECmiz

Watch: IRAEs, Targeted Therapies and Survival Dr. Aurelie Najm discusses OP0270 presented at EULAR 2023 in Milan, Italy. @AurelieRheumo https://t.co/501Rc4SPY1 https://t.co/Ifw93ICqwW

https://bit.ly/43T3FUz

Daily Recap: Day One + Two https://t.co/USBFbTWzGG https://t.co/RV9RyLLNmX

https://bit.ly/3oSvT38

Among 247.3 million US adults. 10.0% (20.3 million) had CVD & 56% were at risk for CVD. Yet only 3.6 million CVD (18%) & 34.5 million at risk for CVD (26%) used wearable devices (compared to 29% in US adults, but less than half wear every day. https://t.co/04xqtkw61x https://t.co/ETTjamvHi2

https://bit.ly/43QYiFo

How to avoid POLYPHARMACY (taking too many medicines). JAMA overview on DE-prescribing. https://t.co/MNmBuuhsFF https://t.co/HQwcsYwj3N

https://bit.ly/43BpFmW

Clinically suspect arthralgias: justified or artefact? At #EULAR23, the perfect platform was provided for an airing of grievances, in a debate entitled ‘Clinically suspect arthralgias: fact or myth’. Dr. Liew ( @drdavidliew ) summarizes the debate. https://t.co/wxLQlTVIaZ https://t.co/F6dJDZBrDk

https://bit.ly/3NbMvfA

What happens when an AI-based symptom checker & an online self-referral tool play Rheumatologists? They don't seem to do great yet! 600 new pts, outw/ 36% dvlpd IA IA Sens 62% Spe 47% Tool Sens 66% Spe 54% More work needed to implement these in practice #EULAR23 @Rheumnow

Using app for self-management in clinical care. There is a need to have continued engagement both patients and clinicians, constantly evolve the product, adapt to the changing needs of patients eg.pre and post pandemic, #WIIFM? @AurelieRheumo @ProfYelizPrior #EULAR2023 @RheumNow https://t.co/5RKog9EMsV

Topics

All News

Do you get our email newsletter?